Schutgens RE - Search Results

1

The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis.

Schutgens RE, Haas FJ, Gerritsen WB, van der Horst F, Nieuwenhuis HK, Biesma DH. Schutgens RE, et al. J Thromb Haemost. 2003 May;1(5):976-81. doi: 10.1046/j.1538-7836.2003.00148.x. J Thromb Haemost. 2003. PMID: 12871364 Free article.

2

The early course of D-dimer concentration following pulmonary artery embolisation.

Mager JJ, Schutgens RE, Haas FJ, Westermann CJ, Biesma DH. Mager JJ, et al. Among authors: schutgens re. Thromb Haemost. 2001 Dec;86(6):1578-9. Thromb Haemost. 2001. PMID: 11776330 No abstract available.

3

Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients.

Schutgens RE, Esseboom EU, Haas FJ, Nieuwenhuis HK, Biesma DH. Schutgens RE, et al. Am J Med. 2002 Jun 1;112(8):617-21. doi: 10.1016/s0002-9343(02)01115-4. Am J Med. 2002. PMID: 12034410

4

No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations.

Schutgens RE, Haas FJ, Ruven HJ, Spannagl M, Horn K, Biesma DH. Schutgens RE, et al. Clin Chem. 2002 Sep;48(9):1611-3. Clin Chem. 2002. PMID: 12194950 No abstract available.

5

Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis.

Schutgens RE, Ackermark P, Haas FJ, Nieuwenhuis HK, Peltenburg HG, Pijlman AH, Pruijm M, Oltmans R, Kelder JC, Biesma DH. Schutgens RE, et al. Circulation. 2003 Feb 4;107(4):593-7. doi: 10.1161/01.cir.0000045670.12988.1e. Circulation. 2003. PMID: 12566372 Clinical Trial.

6

[Simplified diagnosis of deep venous thrombosis by applying clinical score and D-dimer concentration].

Schutgens RE, Biesma DH. Schutgens RE, et al. Ned Tijdschr Geneeskd. 2003 Sep 6;147(36):1721-6. Ned Tijdschr Geneeskd. 2003. PMID: 14520796 Review. Dutch.

7

Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.

Schutgens RE, Esseboom EU, Snijder RJ, Haas FJ, Verzijlbergen F, Nieuwenhuis HK, Lisman T, Biesma DH. Schutgens RE, et al. J Lab Clin Med. 2004 Aug;144(2):100-7. doi: 10.1016/j.lab.2004.04.006. J Lab Clin Med. 2004. PMID: 15322504 Clinical Trial.

8

The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.

Schutgens RE, Beckers MM, Haas FJ, Biesma DH. Schutgens RE, et al. Haematologica. 2005 Feb;90(2):214-9. Haematologica. 2005. PMID: 15710574

9

Reduced efficacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosis.

Schutgens RE, Haas FJ, Biesma DH. Schutgens RE, et al. Br J Haematol. 2005 Jun;129(5):653-7. doi: 10.1111/j.1365-2141.2005.05515.x. Br J Haematol. 2005. PMID: 15916688 Free article.

10

Who is at risk for occult cancer after venous thromboembolism?

Beckers MM, Schutgens RE, Prins MH, Biesma DH. Beckers MM, et al. Among authors: schutgens re. J Thromb Haemost. 2006 Dec;4(12):2731-3. doi: 10.1111/j.1538-7836.2006.02223.x. Epub 2006 Sep 21. J Thromb Haemost. 2006. PMID: 17002655 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page